March 23, 2022 Admin Press Releases OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Biosimilar Product 0 0 Read More
March 14, 2022 Admin Press Releases OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico 0 0 Read More
February 15, 2022 Admin Press Releases OcyonBio Appoints Ricardo Zayas as Chief Operating Officer 2 Read More
January 27, 2022 Admin Press Releases OcyonBio Appoints Daniel Chang, CPA, MBA, CPMP, CPIM as Chief Financial Officer 0 Read More
January 20, 2022 Admin Blog Articles Partnership Development Management Organization(PDMO) – CDMO alternative for Gene and Cell Therapy, Virus and Biologics Mfg. 1 Read More
January 20, 2022 Admin Blog Articles Donor Derived Supply Clift Risk(s)- Gene and Cell Therapy Companies 0 Read More
January 20, 2022 Admin Blog Articles, Uncategorized OCYONBIO cGMP space and Viral Manufacturing Capabilities Ready to Go ! 0 Read More
January 20, 2022 Admin Blog Articles Non-Dilutive Funding driven by Business Incentive Office (BIO) by OCYONBIO 0 Read More
January 19, 2022 Admin Press Releases Health Tech: Robert Salcedo On How OcyonBio’s Technology Can Make An Important Impact On Our Overall Wellness 1 Read More